Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision tag was updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a deployment with minor updates or fixes to the page's metadata. This change does not affect the visible content or primary functionality of the study page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe study protocol documentation on the page updated its revision tag to v3.6.4, replacing the previous v3.6.3, indicating a newer version of the documented materials is now referenced.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a small update to the page's metadata/template. No study content, eligibility criteria, or results are impacted.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer build of the site. No changes to the study content or page text are described in the provided data.SummaryDifference0.0%

- Check74 days agoChange DetectedRecruitment status updated to indicate enrollment has ended, and new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added along with a revised footer label (Revision: v3.6.0); the Intervention/Treatment heading formatting is standardized by removing the spaced slash.SummaryDifference0.3%

- Check82 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor revision to the page content.SummaryDifference0.0%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.